SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, estimates ...

Adimea measures dialysis efficiency by determining the reduction in molar concentration of urinary excreted substances in the spent dialysate. Hence, Adimea provides an accurate measurement ...

MARS is an albumin-dialysis-based device that has been used to treat acute-on-chronic liver failure (ACLF). The treatment is based on the removal from the blood of protein-bound toxins ...

For medical device manufacturers, the adoption of MRAM can result in long-term cost savings. MRAM’s high reliability reduces ...

Researchers from the University of British Columbia have developed a "groundbreaking coating" that could make ...

Artivion (NYSE:AORT) this week announced it received FDA humanitarian device exemption (HDE) for its AMDS Hybrid Prosthesis.

Artivion, Inc. announced that the FDA has granted a humanitarian device exemption (HDE) for use of the of the AMDS hybrid ...

Researchers have developed a groundbreaking coating that could make medical devices safer for millions of patients, reducing the risks associated with blood clots and dangerous bleeding.

The system is currently under review by the FDA, with the company expecting approval before the end of Q1 2025. "Sequana ...

The new material, designed to mimic the natural behaviour of blood vessels, could allow for safer use of blood-contacting devices like catheters, stents, blood-oxygenation machines and dialysis ...